• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS2100079 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2021-01-20 齐鲁制药有限公司 QILU Pharmaceutical Co Ltd In Review 2021-01-19 view
CYHS2000074 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2020-01-23 江苏奥赛康药业有限公司 Jiangsu Aosaikang Pharmaceutical Co Ltd In Review 2020-01-22 view
CYHS2000421 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2020-06-29 江苏奥赛康药业有限公司 Jiangsu Aosaikang Pharmaceutical Co Ltd Approval Completed-Pending Certificated 2021-03-30 view
CXHL1401462 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-04-07 view
CXHL1401460 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-04-07 view
CXHL1401458 艾曲泊帕乙醇胺 eltrombopag olamine Active ingredient Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-03-28 view
CXHL1401459 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-04-07 view
CXHL1401461 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(3.1) New Drug Application 2014-11-17 武汉药谷生物工程有限公司 Wuhan Yaogu Bioengineering Co Ltd Certificate Issued 2016-04-07 view
CYHS2000479 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2020-07-04 正大天晴药业集团股份有限公司 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd In Review 2020-07-03 view
CYHS2100188 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(4) Generic Drug 2021-02-09 四川科伦药业股份有限公司 Sichuan Kelun Pharmaceutical Co Ltd In Review 2021-02-08 view
JXHL0700052 Eltrombopag olamine片 eltrombopag olamine Tablet Chemical Drugs(1.1) Import Drug Application 2007-03-22 依格斯(北京)医疗科技有限公司 Excel Pharma Studies Inc;Smithkline Beecham Corporation Certificate Issued 2007-11-29 view
JXHL2000037 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Import Drug Application 2020-02-26 Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation In Review 2020-02-25 view
JXHL2000038 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Import Drug Application 2020-02-26 Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation In Review 2020-02-25 view
JYHB2002251 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs Supplementary Application 2020-11-09 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Novartis Farmaceutica SA In Review 2020-11-07 view
JYHB1900562 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2019-05-22 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Certificate Issued 2019-07-17 view
JYHB2000592 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2020-05-15 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Filed 2020-05-26 view
JYHB1800373 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2018-04-11 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Certificate Issued 2018-08-09 view
JYHB1800798 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2018-07-20 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Certificate Issued 2018-09-04 view
JYHB2000526 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2020-04-29 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Filed 2020-05-12 view
JYHB1800371 艾曲泊帕乙醇胺片 eltrombopag olamine Tablet Chemical Drugs(5.1) Supplementary Application 2018-03-28 Novartis Pharma Schweiz AG Novartis Pharma Schweiz AG;Glaxo Operations UK Ltd Filed 2018-04-12 view